X
X

Tom O'Brien

CEO

Prior to founding Eclipse in 1993, Tom held several leadership positions throughout his career in the medical device industry. Having mastered both disposable and capital equipment sales for companies like C.R. Bard, Tom’s track record of success quickly established Eclipse as the go-to company to launch new technology in the surgical laser industry.

Over time Tom transitioned Eclipse from a leader in the OR surgical laser market to a key player in the aesthetic laser industry. Starting in 2011 Eclipse began a new mission of increasing adoption of Platelet-rich Plasma on a national level.

His vision and leadership has helped Eclipse become one of the most successful medical device companies in its space. Tom’s new mission is to bring game-changing Eclipse technologies in Platelet-Rich Plasma, Microneedling and Shockwave Therapy to the entire globe.

X

Eclipse Offers High Concentration PRP Tube in Canada

Additional clearance furthers Eclipse product growth of popular platelet-rich plasma kits

DALLAS, June 26, 2017 /PRNewswire/ — Eclipse Aesthetics®, LLC., a leading aesthetic and medical manufacturer, announced it is expanding its Eclipse PRP® product line in Canada.

Recently, Health Canada cleared Eclipse PRP® (Health Canada Lic.#99292) products. The company is now offering Eclipse PRP® HC featuring a 22 mL high-concentration tube. The HC tube yields an average of ~11 mL of platelet-rich plasma. The Eclipse PRP® system is also available with the standard 11 mL tube that yields approximately ~6 mL of PRP.

Both tubes can be processed from the Eclipse Easy Spin™ Centrifuge (Health Canada Lic.#99293). Equipped with custom fit tube holders, the centrifuge offers PRP providers the flexibility to process 22 mL or 11 mL tubes from one unit.

Eclipse PRP® is an autologous system that allows for the safe preparation of pure PRP with optimal platelet recovery or 87% ± 10%. Virtually, all red blood cells (RBC) are eliminated from PRP for reduced inflammation. The concentration of pro-inflammatory Granulocytes (GRs) are also highly reduced. This system has been safely used in hundreds of thousands of procedures worldwide.

“Eclipse PRP® products are global best sellers. The system is fast, effective, simple to use, requires minimal steps, and allows for customizable concentration,” said Tom O’Brien, CEO and Founder of Eclipse. “Our company is pleased to now provide the 22 mL PRP kit along with the 11 mL PRP kit to practices in Canada though our distribution partner Salient Medical Solutions.”

“Both tubes offer an incredible value providing both quantity and quality,” said Jay Herman, President of Salient Medical Solutions. “Eclipse PRP® is an innovative system that is not only easy to use, it is available at a lower price per mL when compared to many other PRP kits on the market.”

Eclipse PRP® has been featured in U.S. and International media for its leading-edge cellular collection technology and remarkable results. [link text=’Read More’ url=’http://www.prnewswire.com/news-releases/eclipse-offers-high-concentration-prp-tube-in-canada-300479412.html’]

For USA & Canada visitors: EclipseMedGlobal.com is an international website that has not been evaluated by the United States Food and Drug Administration. Statements and/or claims on this site are not intended to prevent, diagnose, treat or cure any ailments or diseases. Information and product/packaging on this site is for informational purposes only and is not intended as a substitution for advice from a physician or health-care professional. Information shown on this site may describe clearances in countries other than the USA and Canada, hence it may include indications and information that are outside the scope of FDA-cleared labeling.

Do you understand and want to proceed?

 
Yes, please proceed

 

Visit the Eclipse USA Site